Health
Study shows brilacidin strongly inhibits SARS-CoV-2 in laboratory cell lines – News-Medical.Net
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against…
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv* preprint server.
SARS-Cov-2, the pathogen and causative agent of coronavirus disease 19 (COVID-19), has been responsible for more than 1.2…
-
General24 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change
-
General20 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
Business19 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General19 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts